In 2020, World Health Organization (WHO) Member States endorsed the WHO global strategy towards the elimination of cervical cancer. Women living with HIV have a six-fold increased risk of cervical cancer compared to women without HIV. In areas with high HIV prevalence, the fraction of cervical cancer attributable to HIV is high and contributes to the stark disparities seen in cervical cancer burden. WHO is releasing updated screening and treatment recommendations to support countries in achieving the 2030 screening and treatment targets towards the elimination of cervical cancer. Focusing on both cervical cancer prevention and HIV prevention and treatment, including integration of timely cervical cancer screening and treatment with HIV services, can optimize benefits in countries hardest hit by both epidemics. This pre-recorded session will present the new WHO recommendations on screening and treatment to prevent cervical cancer focusing on women living with HIV. It will also include a dialogue between women, advocates, scientists and providers on the implications of these recommendations for increasing access, improving care and saving lives.

• Presentations
• Session recording